Variability in reported histopathology parameters in operated periampullary adenocarcinomas may affect the prognostic weight of the parameters. Standardized axial sectioning produces a higher incidence of involved margins and also seems to produce a lower relative incidence of pancreatic compared with distal bile duct origin and a higher incidence of involved lymph nodes, compared with non-standardized procedure. The aims of this study were to 1) assess how a previously not described standardized pathology procedure, with longitudinal sectioning along the distal bile duct, affects reported tumour origin, margin status and involved lymph nodes, compared with non-standardized procedure, 2) assess if re-evaluation of microscopic slides affects...
Aim: We examined whether introduction of a standardised pancreatic cancer minimum data set improved ...
BACKGROUND: R status represents an important prognostic factors in periampullary cancers. Thus, it ...
AbstractBackgroundIn a previous study we reported an 85% R1 rate for pancreatic cancer following the...
In recent literature and international meetings held, it has become clear that there are significant...
A pancreatoduodenectomy specimen is complex, and there is much debate on how it is best approached b...
A pancreatoduodenectomy specimen is complex, and there is much debate on how it is best approached b...
Background Resectable adenocarcinomas in the pancreatic head, by definition "periamp...
Chemo(radio)therapy is becoming the new standard for patients with locally advanced pancreatic cance...
International audiencePurpose: Using a standardized specimen protocol analysis, this study aimed to ...
Chemo(radio)therapy is becoming the new standard for patients with locally advanced pancreatic cance...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant cancers. A minority (20%...
Pancreatoduodenectomy is one of the most challenging surgical specimens for pathologists. Recently, ...
The purpose of this study was to evaluate the feasibility of a novel dissection technique of surgica...
A pancreatoduodenectomy specimen is complex, and there is much debate on how it is best approached b...
To analyze the R1 rate of the pancreatic head carcinoma resection specimens which delt with a unifie...
Aim: We examined whether introduction of a standardised pancreatic cancer minimum data set improved ...
BACKGROUND: R status represents an important prognostic factors in periampullary cancers. Thus, it ...
AbstractBackgroundIn a previous study we reported an 85% R1 rate for pancreatic cancer following the...
In recent literature and international meetings held, it has become clear that there are significant...
A pancreatoduodenectomy specimen is complex, and there is much debate on how it is best approached b...
A pancreatoduodenectomy specimen is complex, and there is much debate on how it is best approached b...
Background Resectable adenocarcinomas in the pancreatic head, by definition "periamp...
Chemo(radio)therapy is becoming the new standard for patients with locally advanced pancreatic cance...
International audiencePurpose: Using a standardized specimen protocol analysis, this study aimed to ...
Chemo(radio)therapy is becoming the new standard for patients with locally advanced pancreatic cance...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant cancers. A minority (20%...
Pancreatoduodenectomy is one of the most challenging surgical specimens for pathologists. Recently, ...
The purpose of this study was to evaluate the feasibility of a novel dissection technique of surgica...
A pancreatoduodenectomy specimen is complex, and there is much debate on how it is best approached b...
To analyze the R1 rate of the pancreatic head carcinoma resection specimens which delt with a unifie...
Aim: We examined whether introduction of a standardised pancreatic cancer minimum data set improved ...
BACKGROUND: R status represents an important prognostic factors in periampullary cancers. Thus, it ...
AbstractBackgroundIn a previous study we reported an 85% R1 rate for pancreatic cancer following the...